Enterprise Therapeutics
Series BUKJan 2024
Enterprise Therapeutics raised €30M in a Series B round in Jan 2024. The company is based in UK. Investors in the round: Epidarex Capital, Forbion, IP Group and 3 others. Data as of 4 Nov 2026.
Amount raised
€30M
€30,363,900
Native amount
26,000,000 GBP
Stage
Series B
series b
Investors
6
Provenance & confidence
High confidenceAmount
26,000,000 GBP
ECB-at-date → €30M · rate 0.85628 on 2024-01-30
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
6 namedDate
Jan 2024
Round type
series b
Amount (EUR)
€30M